Evidence map›Paper›PMID 26459050›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2016

Radiopharmaceuticals in paraganglioma imaging: too many members on board?

David Taïeb, Rodney J Hicks, Karel Pacak

Open access · bronzeAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Trial
  2. High-specific-activityFuture oncology (London, England) · 2021
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

David TaïebDepartment of Nuclear Medicine, La Timone University Hospital, European Center for Research in Medical Imaging, Aix-Marseille University, 264 rue Saint-Pierre, 13385, Marseille, France. david.taieb@ap-hm.fr.
Rodney J HicksCancer Imaging and Neuroendocrine Tumour Service, Peter MacCallum Cancer Centre, Melbourne, Australia.
Karel PacakProgram in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD), National Institutes of Health, Bethesda, MD, 20892, USA.
Aix-Marseille Université · FREunice Kennedy Shriver National Institute of Child Health and Human Development · USUniversity of Melbourne · AU

Funding

Diagnosis, Pathophysiology And Molecular Biology of Pheochromocytoma and ParagangliomaZIAHD008735 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI PACAK, KAREL · 2009 to 2024
$28.4M
Intramural NIH HHS ZIA HD008735
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

3-IodobenzylguanidineAlgorithmsDiagnostic ImagingFluorodeoxyglucose F18HumansMutationParagangliomaPhenotypePositron-Emission TomographyRadiopharmaceuticalsSuccinate Dehydrogenase3-IodobenzylguanidineFluorodeoxyglucose F18RadiopharmaceuticalsSuccinate Dehydrogenase

Identifiers

PMID26459050
PMCPMC4733412
OpenAlexW2185550721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.